stoxline Quote Chart Rank Option Currency Glossary
  
Health In Tech, Inc. (HIT)
0.8381  0.02 (2.48%)    05-12 16:00
Open: 0.84
High: 0.85
Volume: 261,372
  
Pre. Close: 0.8178
Low: 0.8
Market Cap: 46(M)
Technical analysis
2025-05-12 4:48:46 PM
Short term     
Mid term     
Targets 6-month :  1.01 1-year :  1.18
Resists First :  0.86 Second :  1.01
Pivot price 0.66
Supports First :  0.64 Second :  0.51
MAs MA(5) :  0.73 MA(20) :  0.67
MA(100) :  0 MA(250) :  0
MACD MACD :  -0.2 Signal :  -0.4
%K %D K(14,3) :  89.4 D(3) :  70.6
RSI RSI(14): 44
52-week High :  7.59 Low :  0.51
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ HIT ] has closed above the upper band by 6.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 0% narrower than normal.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.85 - 0.85 0.85 - 0.86
Low: 0.79 - 0.8 0.8 - 0.8
Close: 0.83 - 0.84 0.84 - 0.84
Company Description

Health In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small to medium sized employers. It also provides health intelligence (HI) card to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.

Headline News

Mon, 28 Apr 2025
Health In Tech's CEO Tim Johnson Discusses Company in 2025, Revenue Growth, and Healthcare on "The Street Reports Podcast" Listen Now! - Quantisnow

Mon, 28 Apr 2025
Health In Tech Achieves 56% Revenue Surge: CEO Unveils Ambitious 2025 Vision for Healthcare Innovation - Stock Titan

Mon, 14 Apr 2025
Health In Tech Delivers Record Q1: 56% Revenue Jump Powers Triple-Digit Profit Growth - Stock Titan

Tue, 08 Apr 2025
Q1 2025 Earnings Alert: Health In Tech Sets Critical First Quarter Report Date - Stock Titan

Mon, 17 Mar 2025
Health In Tech Announces Fourth Quarter and Full Year 2024 Financial Results - PR Newswire

Thu, 13 Mar 2025
HIT stock: Here's why Health in Tech dropped 82% - Investorsobserver

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Technology
Industry:
Software - Application
Shares Out 43 (M)
Shares Float 12 (M)
Held by Insiders 71.7 (%)
Held by Institutions 0.2 (%)
Shares Short 170 (K)
Shares Short P.Month 428 (K)
Stock Financials
EPS 0.01
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.25
Profit Margin 4.7 %
Operating Margin 6 %
Return on Assets (ttm) 4.4 %
Return on Equity (ttm) 10.5 %
Qtrly Rev. Growth 56.4 %
Gross Profit (p.s.) 0.38
Sales Per Share 0.52
EBITDA (p.s.) 0
Qtrly Earnings Growth 370.2 %
Operating Cash Flow 3 (M)
Levered Free Cash Flow 2 (M)
Stock Valuations
PE Ratio 41.9
PEG Ratio 0
Price to Book value 3.22
Price to Sales 1.6
Price to Cash Flow 10.65
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android